Revision history of "Longterm omalizumab usefulness within allergic rhinitis"

Jump to navigation Jump to search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • curprev 17:17, 6 November 2024Patiostart5 talk contribs 5,787 bytes +5,787 Created page with "Six clients (66.7%) accomplished initial CR after 1 treatment program and 3 clients (33.3%) attained additional CR after 2 therapy sessions. The chordoma-related signs enhance..."